<unk>  or<unk>  tumor is an aggressive disease which can originate either in the cortex (steroid hormone-producing tissue) or medulla of the<unk>  gland. According to the 2017 WHO classification of<unk>  tumors,<unk>  cortical tumors are subclassified into cortical adenoma, cortical carcinoma, sex cord stromal tumors, adenomatoid tumor, mesenchymal and stromal tumors (myelolipoma, schwannoma), hematological tumors and secondary tumors, whereas tumors of<unk>  medulla are subclassified into pheochromocytoma, paraganglioma, neuroblastic tumors, composite pheochromocytoma, and composite paraganglioma. Pathogenesis includes many genetic pathways, most prominent being Wnt-Beta catenin pathway and also association with other diseases such as multiple endocrine neoplasia (MEN1 and MEN2), familial adenomatous polyposis, Beckwith-Wiedemann syndrome, Li-Fraumeni syndrome, Lynch syndrome,von Hippel-Lindau disease, carney Complex/Syndrome, neurofibromatosis type 1 and congenital<unk>  hyperplasia. Adrenocortical carcinoma is remarkable for the many hormonal syndromes which can occur in patients with steroid hormone-producing ("functional") tumors, including Cushing's syndrome, Conn syndrome, virilization, and feminization.<unk>  can be treated with both medical therapy and surgery depending upon the stage of the tumor.
Adrenal carcinoma
Renal oncocytoma
Adrenal myelolipoma
Adrenocortical carcinoma
Renal cell carcinoma
Metanephric adenoma
Oncocytoma
Adrenocortical carcinoma electrocardiogram